These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 24606388)
1. Antithrombotic treatment for stroke associated with antiphospholipid antibodies. Arachchillage DR; Machin SJ; Cohen H Expert Rev Hematol; 2014 Apr; 7(2):169-72. PubMed ID: 24606388 [TBL] [Abstract][Full Text] [Related]
2. Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. Cohen H; Werring DJ; Chandratheva A; Mittal P; Devreese KMJ; Isenberg DA; J Thromb Haemost; 2023 Oct; 21(10):2963-2976. PubMed ID: 37391096 [TBL] [Abstract][Full Text] [Related]
9. Cessation of oral anticoagulants in antiphospholipid syndrome. Comarmond C; Jego P; Veyssier-Belot C; Marie I; Mekinian A; Elmaleh-Sachs A; Leroux G; Saadoun D; Oziol E; Fraisse T; Hyvernat H; Thiercein-Legrand MF; Sarrot-Reynauld F; Ferreira-Maldent N; de Menthon M; Goujard C; Khau D; Nguen Y; Monnier S; Michon A; Castel B; Decaux O; Piette JC; Cacoub P Lupus; 2017 Oct; 26(12):1291-1296. PubMed ID: 28355985 [TBL] [Abstract][Full Text] [Related]
10. 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. Erkan D; Aguiar CL; Andrade D; Cohen H; Cuadrado MJ; Danowski A; Levy RA; Ortel TL; Rahman A; Salmon JE; Tektonidou MG; Willis R; Lockshin MD Autoimmun Rev; 2014 Jun; 13(6):685-96. PubMed ID: 24468415 [TBL] [Abstract][Full Text] [Related]
11. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients. Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E Lupus; 2007; 16(1):39-45. PubMed ID: 17283584 [TBL] [Abstract][Full Text] [Related]
12. Thrombotic recurrences and bleeding events in APS vascular patients: a review from the literature and a comparison with the APS Piedmont Cohort. Bazzan M; Vaccarino A; Stella S; Bertero MT; Carignola R; Montaruli B; Roccatello D; Shoenfeld Y; Autoimmun Rev; 2013 Jun; 12(8):826-31. PubMed ID: 23219773 [TBL] [Abstract][Full Text] [Related]
13. Towards evidence-based treatment of thrombotic antiphospholipid syndrome. Derksen RH; de Groot PG Lupus; 2010 Apr; 19(4):470-4. PubMed ID: 20353990 [TBL] [Abstract][Full Text] [Related]
14. Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up. Tarr T; Lakos G; Bhattoa HP; Soltesz P; Shoenfeld Y; Szegedi G; Kiss E Clin Rev Allergy Immunol; 2007 Apr; 32(2):131-7. PubMed ID: 17916982 [TBL] [Abstract][Full Text] [Related]
15. [Recurrent thromboses and hemorrhagic complications in patients with antiphospholipid syndrome during therapy with warfarin plus aspirin]. Kondrat'eva LV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Kovalenko TF; Ostriakova EV; Reshetniak TM Ter Arkh; 2010; 82(5):33-9. PubMed ID: 20597268 [TBL] [Abstract][Full Text] [Related]
16. Can anticoagulation be withdrawn in APS patients after aPL negativization? Cuadrado MJ; Tincani A; Enriquez Merayo E; Moschetti L; Sciascia S Autoimmun Rev; 2024 Jan; 23(1):103427. PubMed ID: 37634679 [TBL] [Abstract][Full Text] [Related]
17. A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Ruiz-Irastorza G; Hunt BJ; Khamashta MA Arthritis Rheum; 2007 Dec; 57(8):1487-95. PubMed ID: 18050167 [TBL] [Abstract][Full Text] [Related]